Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Found 12 matches for

Researchers have developed a vaccine that blocks the effects of the main cause of pain in osteoarthritis (OA) - nerve growth factor (NGF) - in mice.

Unrecognizable Senior old woman walking alone with walker on the city street, elderly and disability concept © Shutterstock

EMCAT

Ecological Momentary Computerised Adaptive Testing

HAWAII

The HAWAII Feasibility Study: A multi-centre randomised feasibility study to determine the key indicators of feasibility for a definitive trial of antimicrobial sutures versus standard sutures in hand and wrist trauma surgery in adults aged 18 years old and over.

Hand Research Group

We are a collaborative group of academic researchers, therapists, physicians, and surgeons. We carry out a wide range of studies in patients, including observational studies of disease, basic science studies on patient-donated tissue and clinical trials of new treatments. Our ultimate aim is to improve the care of patients with hand and wrist problems.

Meet the Kennedy team

  • Tonia Vincent
    Tonia Vincent

    Professor of Musculoskeletal Biology & Honorary rheumatologist

Read the paper

Active immunization targeting Nerve Growth Factor attenuates chronic pain behavior in murine osteoarthritis

Annals of Rheumatic Disease, 12 March 2019. doi: 10.1136/annrheumdis-2018-214489

Full paper

In collaboration with

Supported by

Versus Arthritis logo

Find out more about

Similar stories